https://stock.noler.com/us/stock/vincerx-pharma-inc https://stock.noler.com/us/stock/vincerx-pharma-inc/accounts-payable https://stock.noler.com/us/stock/vincerx-pharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/vincerx-pharma-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/vincerx-pharma-inc/accrued-bonuses-current https://stock.noler.com/us/stock/vincerx-pharma-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/vincerx-pharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/vincerx-pharma-inc/accrued-salaries-current https://stock.noler.com/us/stock/vincerx-pharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/vincerx-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/vincerx-pharma-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/vincerx-pharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/vincerx-pharma-inc/aoci https://stock.noler.com/us/stock/vincerx-pharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/vincerx-pharma-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/vincerx-pharma-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/vincerx-pharma-inc/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/vincerx-pharma-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/vincerx-pharma-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/vincerx-pharma-inc/basic-shares https://stock.noler.com/us/stock/vincerx-pharma-inc/business-acquisition-share-price https://stock.noler.com/us/stock/vincerx-pharma-inc/cash https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/vincerx-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/vincerx-pharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/vincerx-pharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/vincerx-pharma-inc/common-stock-held-in-trust https://stock.noler.com/us/stock/vincerx-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/vincerx-pharma-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/vincerx-pharma-inc/common-stock-value https://stock.noler.com/us/stock/vincerx-pharma-inc/common-unit-outstanding https://stock.noler.com/us/stock/vincerx-pharma-inc/comprehensive-income https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/vincerx-pharma-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/vincerx-pharma-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/vincerx-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/vincerx-pharma-inc/current-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/vincerx-pharma-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/vincerx-pharma-inc/current-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-offering-costs https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/vincerx-pharma-inc/depreciation https://stock.noler.com/us/stock/vincerx-pharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/vincerx-pharma-inc/derivative-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/derivative-liabilities-current https://stock.noler.com/us/stock/vincerx-pharma-inc/diluted-shares https://stock.noler.com/us/stock/vincerx-pharma-inc/due-to-related-parties-current https://stock.noler.com/us/stock/vincerx-pharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/vincerx-pharma-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/vincerx-pharma-inc/effective-tax-rate https://stock.noler.com/us/stock/vincerx-pharma-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/vincerx-pharma-inc/eps https://stock.noler.com/us/stock/vincerx-pharma-inc/eps-basic https://stock.noler.com/us/stock/vincerx-pharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/vincerx-pharma-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/vincerx-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/vincerx-pharma-inc/foreign-pretax-income https://stock.noler.com/us/stock/vincerx-pharma-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/vincerx-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/government-assistance-amount https://stock.noler.com/us/stock/vincerx-pharma-inc/grants-receivable-current https://stock.noler.com/us/stock/vincerx-pharma-inc/grants-receivable-noncurrent https://stock.noler.com/us/stock/vincerx-pharma-inc/income-tax https://stock.noler.com/us/stock/vincerx-pharma-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/vincerx-pharma-inc/income-taxes-paid https://stock.noler.com/us/stock/vincerx-pharma-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/vincerx-pharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/vincerx-pharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/vincerx-pharma-inc/interest-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/interest-paid-net https://stock.noler.com/us/stock/vincerx-pharma-inc/investing-cash-flow https://stock.noler.com/us/stock/vincerx-pharma-inc/investment-income-interest https://stock.noler.com/us/stock/vincerx-pharma-inc/investment-income-net https://stock.noler.com/us/stock/vincerx-pharma-inc/lease-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/vincerx-pharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/vincerx-pharma-inc/level-3-liability-change https://stock.noler.com/us/stock/vincerx-pharma-inc/level-3-liability-issues https://stock.noler.com/us/stock/vincerx-pharma-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/vincerx-pharma-inc/long-term-investments https://stock.noler.com/us/stock/vincerx-pharma-inc/marketable-securities-current https://stock.noler.com/us/stock/vincerx-pharma-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/vincerx-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/vincerx-pharma-inc/net-income https://stock.noler.com/us/stock/vincerx-pharma-inc/net-income-loss-attributable-to-redeemable-noncontrolling-interest https://stock.noler.com/us/stock/vincerx-pharma-inc/noninterest-expense-offering-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/vincerx-pharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-expenses https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-income https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-liability https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-payments https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/vincerx-pharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/vincerx-pharma-inc/other-current-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/other-income https://stock.noler.com/us/stock/vincerx-pharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/vincerx-pharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/vincerx-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/vincerx-pharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-for-commissions https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/vincerx-pharma-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/vincerx-pharma-inc/preferred-stock-value https://stock.noler.com/us/stock/vincerx-pharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/vincerx-pharma-inc/pretax-income https://stock.noler.com/us/stock/vincerx-pharma-inc/pretax-income-domestic https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/vincerx-pharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/vincerx-pharma-inc/profit-loss https://stock.noler.com/us/stock/vincerx-pharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/vincerx-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/vincerx-pharma-inc/public-float https://stock.noler.com/us/stock/vincerx-pharma-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/vincerx-pharma-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/vincerx-pharma-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/vincerx-pharma-inc/restricted-cash-current https://stock.noler.com/us/stock/vincerx-pharma-inc/restructuring-and-related-cost-cost-incurred-to-date https://stock.noler.com/us/stock/vincerx-pharma-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/restructuring-charges https://stock.noler.com/us/stock/vincerx-pharma-inc/retained-earnings https://stock.noler.com/us/stock/vincerx-pharma-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/vincerx-pharma-inc/share-based-compensation https://stock.noler.com/us/stock/vincerx-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/vincerx-pharma-inc/shares-authorized https://stock.noler.com/us/stock/vincerx-pharma-inc/shares-issued https://stock.noler.com/us/stock/vincerx-pharma-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/vincerx-pharma-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/vincerx-pharma-inc/stock-split-ratio https://stock.noler.com/us/stock/vincerx-pharma-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/vincerx-pharma-inc/sublease-income https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/vincerx-pharma-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/vincerx-pharma-inc/taxes-payable-current https://stock.noler.com/us/stock/vincerx-pharma-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/vincerx-pharma-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/vincerx-pharma-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/vincerx-pharma-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/vincerx-pharma-inc/total-assets https://stock.noler.com/us/stock/vincerx-pharma-inc/total-liabilities https://stock.noler.com/us/stock/vincerx-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/vincerx-pharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/vincerx-pharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/vincerx-pharma-inc/variable-lease-cost https://stock.noler.com/us/stock/vincerx-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/vincerx-pharma-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation